CureDuchenne is the global leader in Duchenne research, patient care and innovation. We are committed to improving the lives of those affected by Duchenne through accelerating research, improving care and empowering the community.

cureduchenne.org
Founded by Paul and Debra Miller in 2003, after their son was diagnosed with the disease, CureDuchenne combines fundraising and venture philanthropy leveraging donor dollars to maximize support for promising research into effective treatments for those suffering from Duchenne. 
With transparency as a core value, investment proceeds are redeployed to support research and other mission critical programs to find a cure.


Charity

Health Care

Non Profit

Research

CureDuchenne

Debra Miller

Patricia Brown Mba

Laura Hameed

Ryan T. Meardon

Lianna Orlando

Michael Kelly

Paul Miller

The Leadership Team at CureDuchenne steers the organization's strategic direction and oversees its mission to combat Duchenne Muscular Dystrophy. Comprising the Founder, CEO, and key executives, this team is responsible for coordinating fundraising efforts, ensuring transparency in investments, and fostering collaboration with researchers and the community to accelerate therapeutic advancements and improve patient care. Their collective expertise drives innovation and maximizes impact for those affected by Duchenne.

Leadership Team

Development and Community Engagement

Marketing and Communications Team

Clinical and Research Team

Leadership Team

About

Team members

Other teams at CureDuchenne

Development and Community Engagement

Marketing and Communications Team

Clinical and Research Team